| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
TSE:APTX
Apotex Health Corp.
|
Aug 13, 2026 | BUY |
Strong Buy
+14.1% avg upside
10 analysts
|
$40.00
12.58% Upside
|
· | · |
|
TSE:CMG
Computer Modelling
|
Aug 13, 2026 | HOLD |
Hold
+103.9% avg upside
10 analysts
|
$5.00
25.54% Upside
|
· | · |
|
TSE:DHT.UN
DRI Healthcare
|
Aug 11, 2026 | BUY |
Strong Buy
+11.2% avg upside
6 analysts
|
$21.00
15.25% Upside
|
· | · |
|
TSE:DCBO
Docebo
|
Aug 10, 2026 | BUY |
Strong Buy
+47.6% avg upside
15 analysts
|
$41.09
25.70% Upside
|
· | · |
|
TSE:MDA
MDA Space Ltd
|
Aug 10, 2026 | BUY |
Strong Buy
+27.0% avg upside
18 analysts
|
$59.00
21.66% Upside
|
· | · |
|
TSE:CIGI
Colliers International Group
|
Jul 31, 2026 | BUY |
Strong Buy
+33.6% avg upside
16 analysts
|
$181.07
23.02% Upside
|
+2.9% | · |
|
TSE:FSV
FirstService
|
Jul 24, 2026 | BUY |
Strong Buy
+23.5% avg upside
15 analysts
|
$243.75
24.41% Upside
|
+3.6% | · |
|
TSE:DTOL
D2L
|
Jul 20, 2026 | BUY |
Strong Buy
+60.6% avg upside
7 analysts
|
$16.00
77.49% Upside
|
-3.7% | · |
|
TSE:DND
Dye & Durham
|
Jul 20, 2026 | HOLD |
Buy
+1129.2% avg upside
7 analysts
|
$2.50
194.03% Upside
|
-20.5% | · |
|
TSE:AIF
Altus Group
|
Jul 20, 2026 | HOLD |
Buy
+14.6% avg upside
10 analysts
|
$53.00
8.87% Upside
|
+12.4% | · |
|
TSE:ENGH
Enghouse Systems
|
Jun 11, 2026 | HOLD |
Hold
+88.2% avg upside
6 analysts
|
$17.00
3.05% Downside
|
+9.9% | · |
|
TSE:WELL
WELL Health Technologies Corp
|
Jun 03, 2026 | BUY |
Strong Buy
+59.0% avg upside
11 analysts
|
$6.00
35.18% Upside
|
-14.1% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.